Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127021331 | 12702133 | 1 | I | 20160823 | 20160831 | 20160831 | EXP | US-ELI_LILLY_AND_COMPANY-US201608011455 | ELI LILLY AND CO | 69.00 | YR | F | Y | 0.00000 | 20160830 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127021331 | 12702133 | 1 | PS | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | Unknown | UNK, UNKNOWN | N | U | 20509 | INJECTION | |||||||
| 127021331 | 12702133 | 2 | SS | GEMZAR | GEMCITABINE HYDROCHLORIDE | 1 | N | U | 20509 | INJECTION | |||||||||
| 127021331 | 12702133 | 3 | SS | ALIMTA | PEMETREXED DISODIUM | 1 | Unknown | UNK, SINGLE | N | U | 0 | INJECTION | |||||||
| 127021331 | 12702133 | 4 | SS | ALIMTA | PEMETREXED DISODIUM | 1 | N | U | 0 | INJECTION | |||||||||
| 127021331 | 12702133 | 5 | SS | ABRAXANE | PACLITAXEL | 1 | Unknown | UNK, UNKNOWN | N | U | 0 | ||||||||
| 127021331 | 12702133 | 6 | SS | ABRAXANE | PACLITAXEL | 1 | N | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127021331 | 12702133 | 1 | Lung adenocarcinoma |
| 127021331 | 12702133 | 2 | Pancreatic carcinoma |
| 127021331 | 12702133 | 3 | Lung adenocarcinoma |
| 127021331 | 12702133 | 4 | Pancreatic carcinoma |
| 127021331 | 12702133 | 5 | Lung adenocarcinoma |
| 127021331 | 12702133 | 6 | Pancreatic carcinoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127021331 | 12702133 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127021331 | 12702133 | Haematuria | |
| 127021331 | 12702133 | Liver disorder | |
| 127021331 | 12702133 | Nephropathy toxic | |
| 127021331 | 12702133 | Neuropathy peripheral | |
| 127021331 | 12702133 | Proteinuria | |
| 127021331 | 12702133 | Renal impairment | |
| 127021331 | 12702133 | Thrombocytopenia | |
| 127021331 | 12702133 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127021331 | 12702133 | 1 | 201601 | 201608 | 0 | |
| 127021331 | 12702133 | 3 | 201608 | 201608 | 0 | |
| 127021331 | 12702133 | 5 | 201601 | 0 |